At EteRNAVax we have developed a family of highly effective nucleic acid transfection agents that are stable at room temperature for extended periods of time. Some of our formulations are stable at 23^oC for over a year.

Our hybrid lipid nanoparticles (hLNPs) can be functionalized for tasks such as target delivery, immune system evasion, etc. Further, they can co-deliver small molecule hydrophobic drugs.